ABBV

Here Is How I Find Stocks Through Comprehensive Stock Research And Due Diligence

2021-04-23

Research Articles

Introduction Subscriber Francisco Machado offered an excellent suggestion that inspired this video on how I conduct comprehensive stock research and due diligence on stocks investing. Here is what he asked me: “Thank you for the video, Chuck. One idea, if you think it may be helpful, would be to show your in depth (as much […]

Building A Dividend Growth Portfolio from Scratch in Today’s Expensive Market

2021-03-17

Research Articles

Introduction Building A Dividend Growth Portfolio Before we talk about a dividend growth portfolio, the stock market as measured by the S&P 500 is at an all-time high. However, that is not what concerns me. What I am worried about is the extremely high relative valuation of the market. To be clear, the market can […]

$ABBV AbbVie Has It All: Growth, Dividend Growth and Compelling Valuation (NYS:ABBV)

2019-06-25

Research Articles

Introduction I have held AbbVie (ABBV) since it was originally spun off from Abbott Labs.  Moreover, I have been aggressively adding to my position for clients needing current income and dividend growth.  All in all, it has been an excellent performer in spite of the fact that it is being ridiculously undervalued by Mr. Market.  […]

10 More of 50 Fairly-Valued Dividend Growth Stocks Offering Moderately High Yields: Part 2

2018-04-10

Research Articles

Introduction This is the second of a five-part series presenting 50 dividend growth stocks that I have screened for current fair value.  With this article I will be covering 10 additional dividend growth research candidates in addition to the initial 10 that I presented in part 1 found here. Furthermore, I wanted to be clear […]

Finding Value In The S&P 500: 9 Healthcare Dividend Growth Stocks: Part 1

2016-08-04

Research Articles

Introduction Most everyone would agree that the stock market as measured by the S&P 500 is not cheap today.  However, there might be a great deal of disagreement regarding precisely how overvalued the S&P 500 currently is.  Nevertheless, I would agree that in the general sense, stocks are not exactly bargains today.  This might especially […]

5 Attractive Biotechnology Stocks for Healthy Long-term Returns

2016-06-10

Research Articles

Introduction I am a fervent believer that investors are best served by investing towards a specific investment objective that suits their own unique goals, objectives and risk tolerance.  In other words, investing is not always trying to get the highest possible total returns.  If that were true, no one would have ever invested in bonds, […]

Unlock data on thousands of companies

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.